COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology
Giuseppe Rosano
(1)
,
Ewa A Jankowska
(2)
,
Robin Ray
(3, 4)
,
Marco Metra
(5, 6)
,
Magdy Abdelhamid
(7)
,
Stamatis Adamopoulos
(8)
,
Stefan D Anker
(9, 10)
,
Antoni Bayes‐genis
(11, 12, 13)
,
Yury Belenkov
(14)
,
Tuvia Ben Gal
(15)
,
Michael Böhm
(16)
,
Ovidiu Chioncel
(17)
,
Alain Cohen‐solal
(18, 19)
,
Dimitrios Farmakis
(20)
,
Gerasimos Filippatos
(21)
,
Arantxa González
(22)
,
Finn Gustafsson
(23)
,
Loreena Hill
(24)
,
Tiny Jaarsma
(25)
,
Fadi Jouhra
(3, 4)
,
Mitja Lainscak
(26)
,
Ekaterini Lambrinou
(27)
,
Yury Lopatin
(28)
,
Lars H Lund
(29)
,
Davor Milicic
(30)
,
Brenda Moura
(31)
,
Wilfried Mullens
(32, 33)
,
Massimo F Piepoli
(34)
,
Piotr Ponikowski
(2)
,
Amina Rakisheva
(35)
,
Arsen Ristic
(36)
,
Gianluigi Savarese
(29)
,
Petar Seferovic
(36, 37)
,
Michele Senni
(38, 39)
,
Thomas Thum
(40)
,
Carlo G Tocchetti
(41)
,
Sophie van Linthout
(42, 10)
,
Maurizio Volterrani
(1)
,
Andrew J S Coats
(43)
1
IRCCS San Raffaele [Rome, Italy]
2 Wrocław Medical University
3 University of London [London]
4 St George’s University Hospitals
5 UniBs - Università degli Studi di Brescia = University of Brescia
6 Civic Hospital of Brescia
7 Cairo University
8 OCSC - Onassis Cardiac Surgery Center [Athens]
9 Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
10 BIH - Berlin Institute of Health
11 UB - Universitat de Barcelona
12 ISC - Instituto de Salud Carlos III [Madrid]
13 GTPUH - Germans Trias i Pujol University Hospital [Badalona, Barcelona, Spain]
14 Sechenov First Moscow State Medical University
15 TAU - Tel Aviv University
16 Universität des Saarlandes [Saarbrücken]
17 UMPCD - University of Medicine and Pharmacy “Carol Davila” Bucharest
18 MASCOT (UMR_S_942 / U942) - Marqueurs cardiovasculaires en situation de stress
19 Hôpital Lariboisière-Fernand-Widal [APHP]
20 UCY - University of Cyprus [Nicosia]
21 NKUA - National and Kapodistrian University of Athens
22 CIMA - Center for Applied Medical Research [Plamplona]
23 UCPH - University of Copenhagen = Københavns Universitet
24 QUB - Queen's University [Belfast]
25 LIU - Linköping University
26 University of Ljubljana
27 Cyprus University of Technology
28 VSMU - Volgograd State Medical University [Russian Federation]
29 Karolinska University Hospital [Stockholm]
30 University of Zagreb
31 Universidade do Porto = University of Porto
32 UHasselt - Hasselt University
33 ZOL - Ziekenhuis Oost-Limburg
34 UNIPR - Università degli studi di Parma = University of Parma
35 KazNU - Al-Farabi Kazakh National University [Almaty]
36 University of Belgrade [Belgrade]
37 SASA - Serbian Academy of Sciences and Arts
38 Azienda Ospedaliera Ospedale Papa Giovanni XXIII [Bergamo, Italy]
39 UNIMIB - Università degli Studi di Milano-Bicocca = University of Milano-Bicocca
40 Fraunhofer ITEM - Fraunhofer Institute for Toxicology and Experimental Medicine
41 University of Naples Federico II = Università degli studi di Napoli Federico II
42 DZHK - German Center for Cardiovascular Research
43 University of Warwick [Coventry]
2 Wrocław Medical University
3 University of London [London]
4 St George’s University Hospitals
5 UniBs - Università degli Studi di Brescia = University of Brescia
6 Civic Hospital of Brescia
7 Cairo University
8 OCSC - Onassis Cardiac Surgery Center [Athens]
9 Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
10 BIH - Berlin Institute of Health
11 UB - Universitat de Barcelona
12 ISC - Instituto de Salud Carlos III [Madrid]
13 GTPUH - Germans Trias i Pujol University Hospital [Badalona, Barcelona, Spain]
14 Sechenov First Moscow State Medical University
15 TAU - Tel Aviv University
16 Universität des Saarlandes [Saarbrücken]
17 UMPCD - University of Medicine and Pharmacy “Carol Davila” Bucharest
18 MASCOT (UMR_S_942 / U942) - Marqueurs cardiovasculaires en situation de stress
19 Hôpital Lariboisière-Fernand-Widal [APHP]
20 UCY - University of Cyprus [Nicosia]
21 NKUA - National and Kapodistrian University of Athens
22 CIMA - Center for Applied Medical Research [Plamplona]
23 UCPH - University of Copenhagen = Københavns Universitet
24 QUB - Queen's University [Belfast]
25 LIU - Linköping University
26 University of Ljubljana
27 Cyprus University of Technology
28 VSMU - Volgograd State Medical University [Russian Federation]
29 Karolinska University Hospital [Stockholm]
30 University of Zagreb
31 Universidade do Porto = University of Porto
32 UHasselt - Hasselt University
33 ZOL - Ziekenhuis Oost-Limburg
34 UNIPR - Università degli studi di Parma = University of Parma
35 KazNU - Al-Farabi Kazakh National University [Almaty]
36 University of Belgrade [Belgrade]
37 SASA - Serbian Academy of Sciences and Arts
38 Azienda Ospedaliera Ospedale Papa Giovanni XXIII [Bergamo, Italy]
39 UNIMIB - Università degli Studi di Milano-Bicocca = University of Milano-Bicocca
40 Fraunhofer ITEM - Fraunhofer Institute for Toxicology and Experimental Medicine
41 University of Naples Federico II = Università degli studi di Napoli Federico II
42 DZHK - German Center for Cardiovascular Research
43 University of Warwick [Coventry]
Résumé
Patients with heart failure (HF) who contract SARS-CoV-2 infection are at a higher risk of cardiovascular and non-cardiovascular morbidity and mortality. Regardless of therapeutic attempts in COVID-19, vaccination remains the most promising global approach at present for controlling this disease. There are several concerns and misconceptions regarding the clinical indications, optimal mode of delivery, safety and efficacy of COVID-19 vaccines for patients with HF. This document provides guidance to all healthcare professionals regarding the implementation of a COVID-19 vaccination scheme in patients with HF. COVID-19 vaccination is indicated in all patients with HF, including those who are immunocompromised (e.g. after heart transplantation receiving immunosuppressive therapy) and with frailty syndrome. It is preferable to vaccinate against COVID-19 patients with HF in an optimal clinical state, which would include clinical stability, adequate hydration and nutrition, optimized treatment of HF and other comorbidities (including iron deficiency), but corrective measures should not be allowed to delay vaccination. Patients with HF who have been vaccinated against COVID-19 need to continue precautionary measures, including the use of facemasks, hand hygiene and social distancing. Knowledge on strategies preventing SARS-CoV-2 infection (including the COVID-19 vaccination) should be included in the comprehensive educational programmes delivered to patients with HF.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée